Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
7.53M
-
Shares change
-
+7.53M
-
Total reported value, excl. options
-
$52.8M
-
Value change
-
+$52.8M
-
Number of buys
-
16
-
Price
-
$7.01
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2016
16 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q2 2016.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.53M shares
of 77M outstanding shares and own 9.79% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.09M shares), Cormorant Asset Management, LLC (1.99M shares), Rock Springs Capital Management LP (1.35M shares), PERCEPTIVE ADVISORS LLC (635K shares), Hillhouse Capital Management, Ltd. (600K shares), SPHERA FUNDS MANAGEMENT LTD. (300K shares), Marshall Wace LLP (160K shares), Alyeska Investment Group, L.P. (150K shares), Iguana Healthcare Management, LLC (75K shares), and MILLENNIUM MANAGEMENT LLC (69.2K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.